Idera Pharmaceuticals, Inc. (IDRA) Announces Appointment Of Julian Baker And Dr. Kelvin Neu To Its Board Of Directors
3/12/2014 7:30:58 AM
Idera Pharmaceuticals, Inc. (Nasdaq: IDRA), a clinical stage biopharmaceutical company developing a novel therapeutic approach for the treatment of autoimmune diseases and genetically defined forms of B-cell lymphoma, today announced that Baker Brothers Investments’ Julian C. Baker and Kelvin M. Neu, M.D., joined its Board of Directors, effective March 10, 2014. Founded in 2000, Baker Brothers Investments manages long-term investment funds focused on publicly traded life sciences companies, for major university endowments and foundations.
Help employers find you! Check out all the jobs and post your resume.
comments powered by